{"id":26716,"date":"2021-01-18T18:33:40","date_gmt":"2021-01-18T18:33:40","guid":{"rendered":"http:\/\/cmshub.wpengine.com\/?p=332140"},"modified":"2024-11-03T15:15:49","modified_gmt":"2024-11-03T15:15:49","slug":"breast-cancer-patients-with-low-breast-density-may-be-more-likely-to-suffer-from-lymphedema","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/breast-cancer-patients-with-low-breast-density-may-be-more-likely-to-suffer-from-lymphedema\/","title":{"rendered":"Breast Cancer Patients with Low Breast Density May Be More Likely to Suffer from Lymphedema"},"content":{"rendered":"

<\/span><\/p>\n

High breast density has been linked to a potentially increased risk of breast cancer, and it can also make cancer harder to detect on a mammogram. However, a new study suggests that people with low breast density may not actually have the better lot in life after all.<\/span><\/p>\n

The study, published in JAMA Network Open<\/a><\/em>, found that breast cancer patients with lower breast density ratings were more likely to develop severe lymphedema.<\/span><\/p>\n

Researchers believe that their findings may help doctors predict their patients\u2019 risk of developing severe lymphedema before starting breast cancer treatment. They used a multivariate linear regression model that combines density with other known risk factors to predict the development of lymphedema. The model can ultimately provide estimates of lymphedema severity.<\/span><\/p>\n

<\/span>
Photo: Adobe Stock\/Ruslana<\/a><\/span><\/figcaption><\/figure>\n

\u201cPredictions of lymphedema occurrence and morbidity can help triage patients for increased disease monitoring and thus allow for earlier diagnosis and optimal management of this condition,\u201d the authors wrote. \u201cSuch predictions also can assist in risk stratification in future clinical trials on novel therapeutic interventions for lymphedema.\u201d<\/span><\/p>\n

The research team analyzed 373 cancer patients<\/a> with an average age of 52.3 years. Each of them had already completed curative treatment for an initial breast cancer diagnosis, but some were undergoing follow-up treatments.<\/span><\/p>\n

<\/span>
Photo: Adobe Stock\/RFBSIP<\/a><\/span><\/figcaption><\/figure>\n

\u201cThis study identified 5 readily available clinical factors, including patient, cancer, and treatment factors, that can be used to generate volumetric estimates of lymphedema severity in patients with breast cancer,\u201d the study authors wrote. \u201cTo our knowledge, this study is the first to use mammographic breast density as an independent prognostic factor for lymphedema risk and to provide volumetric estimates of lymphedema morbidity.\u201d<\/span><\/p>\n

<\/span><\/p>\n

Article continues below<\/span><\/p>\n

Our Featured Programs<\/span><\/h5>\n

See how we\u2019re making a difference for People, Pets, and the Planet and how you can get involved!<\/span><\/p>\n<\/p><\/div>\n

<\/span>
Photo: Adobe Stock\/zefart<\/a><\/span><\/figcaption><\/figure>\n

\u201cThis model underscores that lymphedema is a multifactorial disease involving patient, cancer, and treatment factors,\u201d wrote the researchers. \u201cTo our knowledge, this study is the first to not only report the use of diagnostic mammographic breast density as a prognostic factor for lymphedema risk but also provide volumetric estimates of lymphedema severity.\u201d<\/span><\/p>\n

Some limitations of this study include its retrospective nature and missing data. However, one of the study\u2019s strengths was that all patients were receiving care at the same medical facility<\/a>, so their care was provided fairly uniformly, and information was recorded the same way across the board. We look forward to seeing more research on this topic to corroborate its results.<\/span><\/p>\n

\n

<\/p>\n

Provide Mammograms<\/h5>\n

Support those fighting Breast Cancer at The Breast Cancer Site<\/span> for free! \u2192<\/span><\/p>\n<\/div>\n